Interview: Augusto Mitidieri – CEO, Sintetica, Switzerland

augusto-mitidieri-ceo-sinteticaSintetica, Switzlerland’s longtime leader in local anesthesia and pain relief with development efforts in neuromodulation, started an ambitious internationalization strategy in 2011. CEO Augusto Mitidieri discusses the company’s expansion progress and highlights areas of unmet medical need around anesthetics. What are the most significant unmet medical needs in the realm of local anesthetics? There are three main unmet needs in the field of anesthesia that Sintetica has developed strategies to address.
"There is room for significant improvement in the way that acute post-surgical pain, experienced in the 24 hours following surgery, is managed"
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report